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Abstract: Traditional Chinese medicine is gradually becoming a new source of anticancer 
drugs. One such example is wogonin, which is cytotoxic to various cancer cell lines in vitro. 
However, due to its low water solubility, wogonin is restricted to clinical administration. 
Recently, the application of drug-coated magnetic nanoparticles (MNPs) to increase water 
solubility of the drug and to enhance its chemotherapeutic efficiency has attracted much 
attention. In this study, wogonin was conjugated with the drug delivery system of MNPs by 
mechanical absorption polymerization to fabricate wogonin-loaded MNPs. It was demonstrated 
that MNPs could strengthen wogonin-induced cell inhibition, apoptosis, and cell cycle arrest in 
Raji cells by   methylthiazol tetrazolium assay, flow cytometer assay, and nuclear 4′,6-  diamidino-
2-phenylindole staining. Furthermore, the molecular mechanisms of these phenomena were 
explored by western blot, in which the protein levels of caspase 8 and caspase 3 were increased 
significantly while those of survivin and cyclin E were decreased significantly in wogonin-MNPs 
group. These findings suggest that the combination of wogonin and MNPs provides a promising 
strategy for lymphoma therapy.
Keywords: wogonin, magnetic nanoparticles, Raji cell, apoptosis, cell cycle, caspase 8, 
caspase 3, survivin, cyclin E
Introduction
Lymphoma is a refractory malignant tumor that originates in the lymphatic system. 
The two main types are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (NHL). 
Statistics show that there were about 74,030 cases of lymphoma diagnosed in the 
US, including 8490 Hodgkin’s lymphoma and 65,540 NHL in 2010. With poor 
  treatment outcomes, NHL is the eighth leading cause of cancer-related death in males 
and the sixth in females in the US.1 The standard chemotherapy regimen of NHL is 
  cyclophosphamide, doxorubicin, vincristine, and prednisone, which plays an   important 
role in the treatment of NHL. Unfortunately, a considerable number of patients 
  undergoing cyclophosphamide, doxorubicin, vincristine, and prednisone relapse 
thereafter or suffer from dose-related side effects and complications. Furthermore, 
stem cell transplantation, as a treatment of curing NHL,2 is too expensive for patients, 
so curative treatment can be achieved in only a minority of NHL patients. Thus, novel 
therapeutic strategies are urgently needed to improve palliative treatment, prolong life 
expectancy, and improve quality of life in patients with lymphoma.
Wogonin (5,7-dihydroxy-8-methoxyflavone; Figure 1), isolated from the roots 
of the traditional Chinese herb Scutellaria baicalensis Georgi, has been recently 
  recognized as a new anticancer drug that possesses cytotoxic effect against a large panel 
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of human cancer cell lines by inducing apoptosis in vitro.3–5 
Accumulating evidence demonstrates that wogonin also 
dramatically inhibits the development and growth of tumors 
in vivo.6 Notably, it has also been reported that wogonin has 
no or very low toxicity to nonmalignant cells.7 However, 
its low water solubility remains a problem, and the healing 
mechanisms of wogonin are still not fully known.
What’s exciting is that advances in nanotechnology have 
provided an innovative paradigm to overcome the problems of 
cancer diagnosis and therapy. Due to large surface-to-volume 
ratio, biodegradable nature, biocompatibility, low toxicity, 
and superparamagnetic property, magnetic nanoparticles 
(MNPs) can not only be used as a diagnostic tool,8 but also 
offer the capabilities of cancer therapeutics.9 Apart from 
improving drug solubility,10 site-specific drug delivery,11 and 
magnetic hyperthermia,12 it was proposed that high doses of 
iron oxide nanoparticles on their own may generate local 
oxidative stress for cancer therapy.13
In the present study, a wogonin-MNPs drug delivery sys-
tem was uploaded for tumor therapy with higher efficiency, 
and the underlying mechanisms were further investigated.
Materials and methods
Main materials
Wogonin (Jiangsu Key Lab Carcinogenesis and   Intervention, 
China Pharmaceutical University, Nanjing, China) was 
  dissolved in dimethyl sulfoxide (Sigma-Aldrich Corpora-
tion, St Louis, MO), stored at −20°C, and then diluted in 
Gibco® Roswell Park Memorial Institute 1640 medium 
(Invitrogen Life Technologies, Carlsbad, CA) with 10% 
fetal bovine serum (Sijiqing Biological Engineering Materi-
als Co, Ltd, Hangzhou, China); the final concentration of 
dimethyl   sulfoxide was less than 0.15%, which did not show 
toxicity against Raji cells.14 Ferric chloride (FeCl3 ⋅ 6H2O), 
ferrous chloride (FeCl2 ⋅ 4H2O), 25% ammonia solution, and 
citric acid monohydrate were purchased from Sinopharm 
Chemical Reagent Co, Ltd, (Shanghai, China); methylthiazol 
  tetrazolium (MTT) from Sigma-Aldrich; Annexin V-  fluorescein 
isothiocyanate Apoptosis Detection Kit and Cell Cycle 
Detection Kit from KeyGen Biotech Co, Ltd, (Nanjing, China); 
4, 6-diamidino-2-phenylindole (DAPI) from   Beyotime Institute 
of Biotechnology (Haimen, China); and monoclonal antibod-
ies, including caspase 3, caspase 8, survivin and cyclin E, were 
supplied by Santa Cruz   Biotechnology (Santa Cruz, CA).
Synthesis of MNPs
MNPs (magnetite Fe3O4) were prepared by coprecipitation 
of FeCl3 and FeCl2 (2:1 molar ratio) in an alkali ammo-
nia solution. Briefly, 2.61 g of FeCl3⋅6H2O and 1.04 g of 
FeCl2 ⋅ 4H2O were mixed in 100 mL of demineralized water 
in a three-necked flask under a nitrogen atmosphere and the 
temperature was increased to 80°C. With constant mechanical 
stirring, 10 mL of ammonia solution was introduced slowly 
to the reaction mixture and the same temperature was main-
tained for another 30 minutes. The precipitates were washed 
several times with demineralized water by magnetic separa-
tion. Thereafter, 1.37 g of citric acid was added to magnetic 
fluid sample and heated to 90°C under continuous stirring for 
90 minutes. The black precipitates were obtained by cooling 
to room temperature and then subjected to dialysis against 
demineralized water in an 8–14 kD cutoff cellulose membrane 
for 48 hours to remove excess unbound citric acid. Finally, the 
products were lyophilized and stored in a 4°C refrigerator.
Preparation of wogonin-MNPs as a drug 
delivery system
Before application in the present experiment, 10% 
  inactivated fetal bovine serum was added to the prepared 
A B
O
O
O OH
OH
Figure 1 Structure of wogonin derived from Scutellaria baicalensis Georgi. (A) S. baicalensis Georgi; (B) molecular structure of wogonin.
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MNPs – well distributed in fresh Roswell Park Memorial Insti-
tute 1640 medium – by using ultrasound treatment to obtain a 
MNP colloidal suspension, as previously reported.15 Various 
concentrations of wogonin were then conjugated with 80 mg/L 
MNPs by mechanical absorption   polymerization at 4°C for 
48 hours, which did not show toxicity against Raji cells.
Cell line and cell culture
NHL cell line Raji was obtained from Jiangsu Institute of 
Hematology (Suzhou, China). The cells were cultured in 
Roswell Park Memorial Institute 1640 with 10% fetal bovine 
serum, 100 U/mL penicillin, and 100 µg/mL streptomycin at 
37°C in a 5% carbon dioxide humidified environment. The cells 
in logarithmic growth phase were used in all experiments.
MTT assay
Raji cells (1 × 104 cells per well) were incubated with either 
MNPs, wogonin, or wogonin-MNPs in 96-well plates for 24, 
48, and 72 hours; 20 µL of MTT solution (5 mg/mL) was 
added to each well at 37°C in the dark for 4 hours. The forma-
zan crystals were solubilized in 200 µL of dimethyl sulfoxide 
in every well, followed by reading the   absorbance at 570 nm 
using a plate reader (Model 550 Microplate Reader; Bio-Rad 
  Laboratories, Tokyo, Japan). Cell viability (%) was expressed 
as: ODtest cells/ODcontrol cells × 100, where OD represents optical 
density. Cell inhibition rate (%) was determined as follows: 
(1–ODtest cells/ODcontrol cells) × 100. Each assay was repeated at 
least three independent times.
Cell cycle analysis
After treatment for 48 hours, the cells were collected by centrifu-
gation (LD25-Z low speed auto balancing centrifuge; Beijing 
Medical Centrifuge Plant, Beijing, China) at 1500 rpm for 
5 minutes and washed with ice-cold phosphate buffered saline, 
and stained with propidium iodide and ribonuclease for 30 min-
utes. The cell cycle was analyzed by flow cytometer (FACSCali-
bur flow cytometer; BD Biosciences, San Jose, CA).
Apoptosis assay
After 48 hours incubation in the medium containing different 
drugs at 37°C, Raji cells were collected and washed twice 
with phosphate buffered saline and centrifuged at 2000 rpm 
for 5 minutes. The cells were then suspended in 500 µL 
  binding buffer and 5 µL Annexin V-fluorescein isothiocya-
nate, and incubated for 15 minutes at room temperature in 
the dark. The apoptotic cells were analyzed by flow cytometer 
with CellQuest™ software (FACSCalibur; BD Biosciences). 
Both early (Annexin V-positive, propidium iodide-negative) 
and late (Annexin V-positive, propidium iodide-negative) 
apoptotic cells were included in cells death determinations.
DAPI staining
Raji cells were treated for 48 hours, collected, and smeared. 
The cells were then fixed with methanol for 10 minutes 
and stained with DAPI for 15 minutes. Thereafter, the cells 
were observed under fluorescence microscope (B×51 Epi-
Fluorescence Microscope; Olympus, Tokyo, Japan).
Western blot analysis
After experimental treatment, total protein was isolated on ice 
and subjected to 10% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis gels using modified radio immunoprecipitation 
assay buffer, and then transferred to a polyvinylidene difluoride 
membrane (65421; Pall Corporation, Port Washington, NY). The 
blots were stained with primary monoclonal antibodies, either 
anti-caspase 3, caspase 8, survivin, or cyclin E overnight at 4°C, 
and then with horseradish peroxidase conjugated goat anti-rabbit 
or mouse secondary antibody for 1 hour at room temperature. 
The protein bands were detected with an Amersham enhanced 
chemiluminescence detection system (RPN2135; GE Health-
care Life Sciences, Little Chalfont, UK). After normalization 
by the corresponding expression of β-actin, protein expression 
levels were determined by densitometry scans (Photoshop CS5 
Extended, Adobe Systems Inc, San José, CA).
Statistical analysis
Data were expressed as mean ± standard deviation from 
triplicate experiments and analyzed with IBM SPSS (v 13.0; 
SPSS Inc, Chicago, IL). Differences were evaluated using 
one-way analysis of variance or Student’s t-test. P , 0.05 
was considered statistically significant.
Results
Characterization of MNPs
The magnetic iron oxide nanoparticles with a spherical shape 
had an average size of 18 nm determined by transmission 
electron microscope (Figure 2A). As shown in Figure 2B, 
the diameter of MNPs ranged from 5 nm to 30 nm. The 
hydrodynamic diameter of the citric acid-coated magnetic 
particles was 38.9 ± 1.2 nm with a narrow polydispersity 
(0.293 ± 0.007) based on photon correlation spectroscopy 
(Nicomp 380; Particle Sizing Systems, Santa Barbara, CA) 
(Figure 2C). In the present study, citric acid-coated MNPs did 
not settle down under the influence of the magnet, suggesting 
that the colloidal solution was stable. It was also observed 
that wogonin did not precipitate in the colloidal suspension 
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of the wogonin-MNPs drug delivery system after 2 months 
of storage, which indicates that the solubility of wogonin 
was improved by MNPs.
Cell growth inhibition
MTT assays were carried out to explore cell viability and 
inhibition rate of lymphoma cancer cells after being coincu-
bated with different concentrations of wogonin or wogonin-
MNPs with equivalent wogonin concentration for 24, 48, 
and 72 hours. As shown in Figures 3 and 4, results suggest 
that wogonin-MNPs could inhibit growth of Raji cells more 
effectively than wogonin alone (P , 0.05). Notably, there was 
no significant difference between MNPs alone and control 
group (P . 0.05), which confirmed their low cytotoxicity.
Cell cycle arrest
The effects of MNPs, wogonin, and wogonin-MNPs on the cell 
cycle were investigated by flow cytometry at 48 hours. Results 
showed an increased amount of the cell population in G0/G1 
phase. Notably, the shift of cell distribution into the G0/G1 phase 
was increased in a dose-dependent manner and augmented by 
MNPs (Figure 5; Table 1). There was no significant difference 
between MNPs alone and control group (P . 0.05).
Enhancement of apoptosis
Apoptotic rates of Raji cells were examined with Annexin V 
propidium iodide double-staining assay. Flow cytometry 
results show that the proportion of apoptotic cells in wogonin-
MNPs group increased significantly compared with that in 
wogonin group (P , 0.05). However, there was no significant 
difference between MNPs alone and control group (P . 0.05) 
(Figure 6). Notably, apoptotic rates in Raji cells treated with 
wogonin increased in a dose-dependent manner, which were 
higher when combined with MNPs. All these results further 
strengthen the possibility that MNPs could strengthen the 
effect of wogonin on cell apoptosis.
Morphologic characterization  
of apoptosis
Nucleolus changes of Raji cells under fluorescence microscope 
are shown in Figure 7. Raji cells with equably blue fluorescence 
in MNPs alone and control group demonstrated that chromatin 
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Figure 2 Physical characteristic of the citric acid-coated magnetic particles. (A) Transmission electron microscopic images of magnetic nanoparticles; (B) size distribution 
histogram of magnetic nanoparticles; (C) hydrodynamic particle size distribution of citric acid-coated magnetic particles.
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equably distributed in the nucleolus. However, after treatment 
with various concentrations of wogonin and wogonin-MNPs, 
Raji cells displayed the typical features of apoptosis, such as 
chromatin condensation, nucleolus pyknosis, nuclear fragmen-
tation, and apoptotic bodies. Notably, it was more evident that 
the features of apoptosis in the cells incubated with wogonin-
MNPs were observed compared to wogonin alone.
Expression of caspase 3, caspase 8, 
survivin, and cyclin E
Based on computer-assisted image analysis, it was dem-
onstrated that survivin, caspase 3, and caspase 8 proteins 
in Raji cells treated with 80 mg/L MNPs for 48 hours had 
no significant changes when compared with control group 
(P . 0.05). However, caspase 3 and caspase 8 expression 
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Discussion
The high toxicity of anticancer drugs to normal tissues is 
the biggest obstacle of cancer therapy, which restricts the 
application of antineoplastics.16 Enhancing the efficacy of 
chemotherapy and ameliorating the side effects of cancer 
chemotherapies are the major goals in the development of 
tumor treatment.17 With negligible toxicity to nonmalignant 
cells,7 wogonin, a remedy in traditional Chinese medicine, 
is becoming an attractive candidate for the development 
of a new anticancer drug. It has been demonstrated that 
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in Raji cells treated with either wogonin or wogonin-MNPs 
for 48 hours were upregulated compared with MNPs alone 
(P , 0.05). The level of survivin was downregulated in 
wogonin group, and this downregulation was further aug-
mented in wogonin-MNPs group. In addition, the expres-
sion of cyclin E, which did not significantly change when 
Raji cells were treated with wogonin alone (P . 0.05), 
was dramatically downregulated in Raji cells treated with 
wogonin-MNPs compared with other groups (P , 0.05) 
(Figure 8).
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wogonin possesses a direct cytotoxicity to a large panel 
of human malignant cell lines in vitro3–5 and suppresses 
tumor growth in vivo.6 Outcomes in the present study 
indicate that wogonin can inhibit the growth of Raji cells 
in a dose- and time-dependent manner. However, the cur-
rent barrier to clinical application of wogonin is its low 
water solubility (,100 µmol/L), which was observed in 
the present experiment.
In order to overcome such limitation, many strategies, 
such as delivery of drugs by nanocarriers, have been designed 
to solve problems exhibited by conventional “free” drugs, 
including limited stability, poor solubility, rapid clearing, and, 
in particular, lack of selectivity.18 With satisfactory chemical 
stability, favorable toxicity profile, and superparamagnetic 
property, the use of MNPs has emerged as an innovative 
theranostic.19–21 However, large surface-to-volume ratio and 
magnetic property of iron oxide nanoparticles in nature 
make them aggregate in aqueous media, seriously impeding 
their biomedical application.22 Citric acid, as a stabilizer, 
not only makes MNPs stable in biological liquids but also 
provides the uncoordinated carboxyl groups for further 
functionalization.23 Thus, citric acid-modified MNPs were 
fabricated. Under the influence of a magnet, MNPs were 
not observed to settle down, which confirmed the stabil-
ity of the colloidal solution. One of the most important 
factors that determines biomedical applications of MNPs   
is hydrodynamic size. MNPs ,10 nm are subject to tissue 
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Figure 6 Apoptotic rates of Raji cells treated with magnetic nanoparticles, wogonin, or wogonin-magnetic nanoparticles for 48 hours. (A) Control group; (B) 80 mg/L magnetic 
nanoparticles; (C) 12.5 µmol/L wogonin; (D) 12.5 µmol/L wogonin-magnetic nanoparticles; (E) 50 µmol/L wogonin; (F) 50 µmol/L wogonin-magnetic nanoparticles. 
Abbreviations: FITC-H, peak height of fluorescein isothiocyanate channel; MNPs, magnetic nanoparticles; PI, propidium iodide; PE-H, peak height of phycoerythrin channel; 
Q1, necrosis; Q2, late apoptosis; Q3, healthy cells; Q4, early apoptosis.
Table 1 Cell cycle distributions of Raji cells
Group Cell cycle phase
G0/G1 G2/M S
Control group 46.27 ± 1.36 14.88 ± 0.61 38.85 ± 1.52
80 mg/L MNPs 52.69 ± 2.16 16.15 ± 0.28 31.16 ± 1.91
12.5 µmol/L wogonin 66.90 ± 2.32 2.37 ± 0.93 30.73 ± 1.87
50 µmol/L wogonin 70.58 ± 0.98 0 29.41 ± 0.98
12.5 µmol/L wogonin-MNPs 71.58 ± 0.77 0 28.42 ± 0.77
50 µmol/L wogonin-MNPs 75.12 ± 1.63 0 24.88 ± 1.63
Note: Mean ± standard deviation, %.
Abbreviation: MNPs, magnetic nanoparticles.
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extravasation and renal clearance, whereas those .100 nm 
are quickly opsoninized and eliminated from circulation via 
the reticuloendothelial system.19 Gupta and Wells24 reported 
that the hydrodynamic diameter of well-designed MNPs 
ranges from 10 nm to 100 nm, which is optimal for in vivo 
applications. In the present study, the fabricated citric acid-
functionalized MNPs, 18 nm in size, were up to grade and 
suitable for drug delivery. It was noteworthy that MNPs 
could not only improve water solubility but also substantially 
augment the anticancer efficacy of wogonin, especially with 
a low dose of wogonin or long incubation time; even when 
the concentration of MNPs was up to 80 mg/L, they showed 
no obvious toxicity to Raji cells. These results suggest that 
MNPs are a promising and simple drug carrier for cancer 
therapy, which is reinforced by previous studies that demon-
strated that intracellular drug concentration could increase via 
nanoparticle-mediated endocytosis25 and that fluctuations in 
drug levels could be avoided by providing sustained release 
of drugs to enhance the anticancer efficacy.10
The cell cycle is a series of events that take place in a 
cell leading to its division and duplication. Regulation of 
the cell cycle involves processes crucial to the survival of a 
cell. The G1/S checkpoint and G2/M checkpoint monitor and 
regulate the progress of the cell cycle, so regulation of the 
cell cycle is favorable to the treatment of cancer. Recently, 
Min reported that wogonin exerted potential induction of 
cycle arrest at G0/G1 phase in several cancer cell lines.17 In 
the present study, an accumulation of cells in G0/G1 phase was 
similarly observed in wogonin-treated Raji cells. Notably, the 
shift of cell distribution into the G0/G1 phase was augmented 
by MNPs. Further studies should be investigated to elucidate 
the mechanism of the shift.
Cell cycle progress is the result of an orchestrated inter-
action between several proteins, such as cyclins and cyclin-
dependent kinases, which determine a cell’s progress 
through the cell cycle. It is well known that cyclin D-CDK4/6 
complex and cyclin E-CDK2 complex are crucial for G1 
checkpoint control. Exposure of different cancer cell lines 
to wogonin was previously shown to decline cyclin D pro-
tein levels, resulting in growth inhibition at G0/G1 phase.17 
  Consistent with this notion, an accumulation of cells in the 
G0/G1 phase was observed in wogonin-treated Raji cells 
Figure 7 Morphologic characterization of Raji cells after different treatments for 48 hours under inverted fluorescence micrographs (100×, 4′,6-diamidino-2-phenylindole 
staining). (A) Control group; (B) 80 mg/L magnetic nanoparticles; (C) 12.5 µmol/L wogonin; (D) 12.5 µmol/L wogonin-magnetic nanoparticles; (E) 50 µmol/L wogonin; (F) 
50 µmol/L wogonin-magnetic nanoparticles.
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Figure 8 Expression of caspase 3, caspase 8, survivin, and cyclin E protein in Raji cells 
by western blot after treatment of wogonin with or without magnetic nanoparticles 
for 48 hours. Lane 1, control group; Lane 2, 80 mg/L magnetic nanoparticles; Lane 3, 
12.5 µmol/L wogonin; Lane 4, 12.5 µmol/L wogonin-magnetic nanoparticles.
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in the present study. Notably, reduced cyclin E protein 
level was observed in Raji cells treated with wogonin-
MNPs. These differing results suggest that there may be 
fundamental differences between cell types. Therefore, 
wogonin-MNPs possess an enormous potential to evoke 
cell cycle arrest at G0/G1 phase via   downregulation of 
cyclin E.
Apoptosis or programmed cell death, which occurs 
after sufficient cellular damage, is a normal component 
of the development and health of multicellular organisms. 
  Dysregulation of apoptosis can disrupt the balance between 
cell growth and cell death and is an important step in the 
development of cancer.26 Evasion of apoptosis has been 
considered as a hallmark of cancer.27 Therefore, activation 
of apoptosis is more widely used as a potential antican-
cer strategy. Results in the present study showed that the 
apoptotic rate of Raji cells treated with wogonin-MNPs 
increased significantly compared with wogonin alone, 
suggesting that MNPs synergistically enhance wogonin-
induced cell apoptosis. Results were also confirmed by 
the typical morphological features of apoptosis in Raji 
cells stained with DAPI after treatment with wogonin or 
wogonin-MNPs.
Apoptotic cell death can be executed by two pathways: 
the death-receptor pathway (extrinsic pathway) and the 
mitochondrial pathway (intrinsic pathway). In both path-
ways, apoptotic death stimulus results in activation of cas-
pases, which are the central executioners of the apoptotic 
pathway.28,29 Initiator caspases, such as caspase 2, 8, 9, 10, 
11, and 12 initiate disassembly in response to extracellular 
apoptosis-inducing ligands and are activated in a complex 
associated with the cytoplasmic death domain of many 
cell-surface ligand receptors. On the other hand, effector 
caspases, such as caspase 3, 6, and 7 are then activated by 
these active initiator caspases through proteolytic cleav-
age and carry out the cell death program. Thus, caspase 8   
and caspase 3 are situated at pivotal junctions in apoptotic 
pathways. In the present study, a significant increase in 
the expression of active caspase 8 and caspase 3 protein 
was observed in Raji cells treated with wogonin and 
wogonin-MNPs, indicating that the extrinsic pathway 
is involved in wogonin-induced apoptotic pathways. 
A recent report suggesting that wogonin could sen-
sitize cancer cells toward TNFα-induced apoptosis 
(extrinsic pathway)30 also strengthens the present findings. 
Moreover, apoptosis is tightly regulated by a fine-tuned 
balance between proapoptotic and antiapoptotic fac-
tors. Survivin, as an inhibitor of apoptosis protein, is   
not   limited to apoptosis inhibition in cancer pathogen-
esis but is also involved in the regulation of the mitotic 
spindle   checkpoint and the promotion of angiogenesis and 
  chemoresistance.31 In the present study, either wogonin 
alone or   wogonin-MNPs increased apoptosis of Raji cells 
and this was accompanied by the downregulation of survivin 
protein. In general, wogonin-MNPs induced cell apoptosis 
through various pathways.
Conclusion
The present study demonstrates that MNPs not only increase 
the water solubility of wogonin but also enhance its therapeu-
tic efficiency via blocking the cell cycle at G0/G1 phase and 
inducing apoptosis of Raji cells. These findings indicate that 
the combination of wogonin and MNPs provides a promising 
strategy for lymphoma therapy.
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